Google DeepMind– tag –
-
Isomorphic Labs Secures $2.9 Billion in Partnerships with Eli Lilly and Novartis, Validating AI Drug Discovery Platform
GeneOnline Taiwan Overview Isomorphic Labs, a Google DeepMind spin-out, has solidified its AI drug discovery platform's value through significant partnerships totaling $2.9 billion with Eli Lilly ($1.7B) and Novartis ($1.2B). Concurrentl... -
AlphaFold2’s Protein Structure Prediction Breakthrough Earns Nobel Prize, Igniting New Era in AI-Driven Drug Discovery
Facebook (Singularity University) UK Overview Google DeepMind's AlphaFold achieved a groundbreaking advance in protein structure prediction in 2020, leading to a Nobel Prize in 2024 for David Baker, Demis Hassabis, and John Jumper. This ... -
CuspAI Secures $450M Series B, Reaching $2.6B Valuation and Launching AI Materials Foundry with Industry Titans
Sifted UK Overview Cambridge-based AI materials discovery startup CuspAI has raised $450 million in Series B funding, pushing its valuation to $2.6 billion. Concurrently, the company launched the "AI Materials Foundry," a global consorti... -
World Fund Analyzes European AI Materials Discovery Ecosystem: DeepMind, Meta AI Models Accelerate Novel Material Development
World Fund Europe Overview World Fund has released an analysis of AI-driven materials discovery, highlighting opportunities in Europe, noting significant advancements since AlphaFold. Emerging AI models like M3GNet, DeepMind's GNoME, Mic... -
Google DeepMind Advances AGI Path with ‘Genie 3,’ a Generative World AI Model Capable of Real-time 3D Environment Generation and Enhanced Reasoning
Wisdomplexus USA Overview Google DeepMind has developed "Genie 3," a generative world AI model designed to deeply understand and simulate physical environments. Genie 3 can generate high-quality 3D environments in real-time from text pro... -
Google DeepMind Unveils Gemini 3.5 Flash Cyber AI, a Specialized Model for Vulnerability Hunting, Outperforming DeepSWE Benchmarks for Government and Trusted Partners
Security Affairs USA Overview Google DeepMind has launched "Gemini 3.5 Flash Cyber," a new AI model specialized in software vulnerability discovery and patching. Built on the existing 3.5 Flash architecture, the model demonstrated 49% pe... -
AI Drug Discovery Enters “Clinical Proof Era” in 2026 with Insilico’s Rentosertib in Phase 3 and Isomorphic Labs’ IsoDDE Nearing Clinical Entry
PharmaADC Unknown Overview The article highlights 2026 as the "era of clinical proof" for AI drug discovery, exemplified by Insilico Medicine's AI-developed rentosertib entering Phase 3 trials for idiopathic pulmonary fibrosis (IPF) in J... -
Xaira Emerges with $1.3 Billion Funding, Seeks Preclinical Data Partners to Fortify AI Drug Discovery Platform
BioNucleus Briefing USA Overview Xaira, an AI drug discovery company, has emerged from stealth after raising $1.3 billion and is actively seeking partners to contribute preclinical datasets to strengthen its AI platform. Emphasizing data... -
Isomorphic Labs’ AlphaFold 3-Designed AI Drug Candidates Enter First-in-Human Clinical Trials for Solid Tumors
IntuitionLabs USA Overview Isomorphic Labs, a Google DeepMind spin-off, has initiated first-in-human clinical trials for oncology candidates designed using AlphaFold 3 and proprietary AI models. This landmark achievement signifies one of... -
IntuitionLabs Compares AlphaFold 3 and ESM3, Highlighting Evolution of AI Biology Foundation Models and Generative Diffusion Superiority
IntuitionLabs Unknown Overview An IntuitionLabs analysis provides a detailed comparison of leading AI biology foundation models like AlphaFold 3 and ESM3. The article focuses on models such as AlphaFold 3, a generative diffusion model fo...
